Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025

/EIN News/ — FREMONT, Calif., Dec. 30, 2024 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company …

Do you trust this headline?

Based on recent headline ratings, 79% of this readership currently trusts the local media, which has an average score of 83% regionally and is currently trending negative.

79%

Media Trust Score